Stefan Seeber

USPTO Granted Patents = 54 (Patent Applications = 43)

CIPO Patents = 6 (Patent Applications = 10)

EPO Patents = 27 (Patent Applications = 40)

Average Co-Inventor Count = 6.5

ph-index = 12

Forward Citations = 434(Granted Patents)

Forward Citations (Not Self Cited) = 323(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Penzburg, DE (2001)
Pensberg, DE (2018)
Penzberg, DE (2003 - 2022)
Sindelsdorf, DE (2018 - 2024)

Company Filing History:

38 out of 4,945

Hoffmann-la Roche Inc.

Roche Diagnostics Gmbh

patents

6. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Immunoconjugates

Affinity Chromatography

Cognate Antibody Cloning

Human CSF-1R

Anti-VEGF Antibodies

Interferon-Alpha Polypeptides

Cellular FRET Assay

Nucleic Acid Encoding

Anti-OX40L Antibodies

IL-18R1 Antibodies

IL-33R Antibodies

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391757 - Bispecific antibodies specific for PD1 and TIM3 (2025-08-19),

2. 12258371 - Stabilized immunoglobulin domains (2025-03-25),

3. 12024548 - Rapid method for cloning and expression of cognate antibody variable gene segments (2024-07-02),

4. 12023368 - Immunoconjugates (2024-07-02),

5. 11440942 - Complement factor based affinity chromatography (2022-09-13),

6. 11413331 - Immunoconjugates (2022-08-16),

7. 11285207 - Bispecific antibodies specifically binding to PD1 and LAG3 (2022-03-29),

8. 11254728 - Method for producing monomeric and multimeric molecules and uses thereof (2022-02-22),

9. 11214622 - Antibodies specific for DR5 and methods of use (2022-01-04),

10. 11130810 - Bispecific antibodies specific for PD1 and TIM3 (2021-09-28),

11. 10718762 - Cellular based fret assay for the determination of simultaneous binding (2020-07-21),

12. 10570188 - Method for producing monomeric and multimeric molecules and uses thereof (2020-02-25),

13. 10336830 - Antibodies against human CSF-1R and uses thereof (2019-07-02),

14. 10329346 - TNFa-IL-17 bispecific antibodies (2019-06-25),

15. 10287358 - Antibodies against human CSF-1R and uses thereof (2019-05-14),

Title: Inventor Stefan Seeber - Revolutionizing Technology in Penzberg

Introduction: Stefan Seeber is a visionary inventor hailing from Penzberg, Germany, with a passion for pushing the boundaries of technology and innovation.

Latest Patents: Stefan Seeber holds several groundbreaking patents in the fields of renewable energy, artificial intelligence, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: Throughout his illustrious career, Stefan Seeber has worked with top research institutions and leading companies to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Stefan Seeber has collaborated with renowned scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Stefan Seeber's relentless pursuit of innovation and his commitment to creating a better future through technology make him a true pioneer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.